Glaucoma clinical trials in Texas
8 studies for Glaucoma are looking for participants at sites in Texas.
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07075718iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07816692Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT04967989Rocklatan vs Latanoprost Post-DSLT
- Eye Centers of Southeast Texas, Beaumont
RecruitingPhase 4
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07465913Change in IOP Fluctuation After DSLT
- Ophthalmology Associates, Fort Worth
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT07428668Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Glaucoma Associates of Texas, Dallas
- University of Texas Southwestern, Dallas
Recruiting
Ages 45 and older · All sexes · Updated Dec 15, 2025 · NCT07220876Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218783From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.